瘤学家和泌尿病学家对细胞癌的辅助治疗的偏好:一个离散选择实验
Caroline Vass1, Cathy Anne Pinto2, Kelley Myers3
1Health Preference Assessment, RTI Health Solutions, Manchester, UK.
Future oncology (London, England)
|February 13, 2025
概括
在选择细胞癌 (RCC) 辅助治疗时,医生优先考虑生存益处而不是副作用风险. 大多数人会建议对高风险的患者进行辅助治疗.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床决策 临床决策
背景情况:
- 辅助疗法在治疗高风险细胞癌 (RCC) 术后的治疗中起着至关重要的作用.
- 了解医生偏好对于优化治疗策略和患者结果至关重要.
研究的目的:
- 量化瘤学家和泌尿病学家对细胞癌 (RCC) 的各种辅助治疗方法的偏好.
- 评估医生愿意在治疗的好处和风险之间做出的权衡.
主要方法:
- 在线进行了一项离散选择实验,与250名董事会认证/符合条件的医生进行了实验.
- 医生根据生存率的改善,副作用概况和其他因素评估假设的辅助疗法.
- 数据使用随机参数逻辑和潜在类模型进行分析.
主要成果:
- 医生优先考虑5年总生存率的改善,其次是无病生存率和减少副作用.
- 医生表现出愿意接受腹,头和疲劳的风险增加,以获得更好的生存结果.
- 在瘤科医生和泌尿科医生之间,以及在整体医生样本中,观察到偏好有显著的异质性.
结论:
- 大多数被调查的医生会推对高风险的腎切除术后RCC患者进行辅助治疗.
- 医生的偏好表明,在选择辅助治疗时,他们非常重视生存益处.
更多相关视频
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.5K
06:39Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Published on: November 22, 2019
7.6K
相关概念视频
01:27Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K